This News From Novo: A Warning for Eli Lilly Shareholders
A GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
Learn why blockchain can operate without Bitcoin, focusing on architecture, governance models, and use cases beyond cryptocurrency.
28,321 articlesA GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
This article breaks down the expected path for synopsys (snps) 2026 earnings, focusing on AI design driver demand, li...
A fresh cash-raising move and a strategic acquisition shook investors in Intuitive Machines. This article breaks down...
As AI expands, the biggest upside may come from the hyperscalers funding the cloud and data centers behind the scenes...
A seasoned financial planner argues that a two-ETF approach can cover most retirement needs, pairing a dividend-based...
NVIDIA and Meta Platforms announced a sweeping AI-infrastructure agreement, driving stock moves and reshaping the rac...
Stocks rally as AI names lead gains, but one gauge shows extraordinary greed. Investors weigh Buffett's caution again...
A new wave of skepticism surrounds the Fed after a high-profile critique from a former governor. This piece explains ...
From top holdings to regulatory risks, this guide breaks down ZKH's Q1 2026 earnings call and translates the numbers ...
As Chewy released its latest earnings, investors faced mixed signals: growing revenue and better margins, but cautiou...
The Northeast is seeing a rapid rise in million-dollar starter homes, reshaping the landscape for millennial parents ...
A popular fallen angel ETF delivers about 6% yield paid monthly by buying bonds downgraded from investment grade. It’...